NetBrain Technologies, Inc., the leading no-code automation platform for hybrid network observability, unveiled significant platform enhancements that further integrate Agentic AI with intent-based ...

Explore how large language models enhance knowledge graphs in drug discovery and improve data management and reasoning.

UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

Ottawa, April 14, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global drug discovery market size was evaluated at USD 65.88 billion in 2024 and is predicted to grow around USD 160.31 ...

Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

To the best of our knowledge, this is the first work for annealing quantum computation to outperform classical results concerning LLM training in drug discovery. This validation has also revealed ...

Strategic Partnership Aims to Create Novel Drug Discovery Pipeline for Unmet Medical Needs by Combining PPI Control Technology with AI Drug Discovery Platform This partnership will accelerate ...